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Introduction {#sec1}
============

The regulation of translation in space and time is essential for a variety of physiological and developmental processes, such as axis specification in *Drosophila* and *Xenopus*, cell migration in fibroblasts, and synaptic plasticity in mammalian neurons ([@bib44]). Capped and polyadenylated mRNAs are by default translationally competent upon their export from the nucleus into the cytoplasm ([@bib30]). However, many mechanisms exist that can alter this default state and silence mRNA translation. Mechanisms include the binding to bona fide repressors ([@bib57]), denying access to ribosomes by inclusion in dense ribonucleoprotein (RNP) bodies ([@bib67]), and preventing access to eIF4E by eIF4E binding proteins ([@bib7], [@bib34], [@bib45], [@bib47], [@bib58], [@bib63], [@bib68]) and by having a reduced poly(A) tail length ([@bib22], [@bib28], [@bib29]). Such translational control can be coupled to mRNA localization so that transcripts are translationally repressed while being transported and only activated when they reach their final destination. In this way, protein function can be targeted to specific subcellular locations with high fidelity.

In the *Drosophila* oocyte, the primary body axes are established through mRNA localization coupled to temporal and spatial regulation of the translation of *oskar* (*osk*), *bicoid* (*bcd*), *nanos* (*nos*), and *gurken* (*grk*) mRNA ([@bib66]). All of these mRNAs are transcribed in the nuclei of the adjoining nurse cells before being deposited in the oocyte and localized. During their transport through the nurse cells and within the oocyte, such transcripts are thought to be maintained in a translationally silent state through a number of mechanisms, including those described above, followed by de-repression or activation at their final destination ([@bib2], [@bib57]). However, it is not known whether the mechanisms of repression of each transcript are the same; nor is it clear how many mechanisms of repression are at play in each case.

Translational regulation of *osk* mRNA, which specifies the posterior of the future embryo and initiates the formation of the posterior germline, has formed the paradigm in the egg chamber for translational control through the binding of specific repressors. During the transport of *osk* mRNA, Bruno (Bru)/Arrest (Aret) binds to Bruno response elements (BREs) in its 3′ UTR. Together with polypyrimidine tract-binding protein (PTB), Bruno binding induces oligomerization of *osk* into translationally silenced particles that contain of up to 250 *osk* transcripts in the stage 10b oocyte ([@bib3], [@bib11], [@bib38], [@bib41]). BREs have been shown to act on *osk* mRNA in *trans*. Therefore, *osk* transcripts can confer Bruno-mediated repression to neighboring *osk* mRNAs within the same RNP ([@bib23], [@bib55]). This association breaks down when *osk* mRNA arrives at the oocyte posterior pole ([@bib11]), allowing its translation. Furthermore, *osk* is subject to an additional parallel mode of translational repression through the action of Cup, the *Drosophila* homolog of the mammalian eukaryotic initiation factor eIF4E binding protein 4E-transporter (4E-T) and functional homolog of *Xenopus* Maskin ([@bib7], [@bib34], [@bib45], [@bib47], [@bib48], [@bib58], [@bib63]).

Cup represses *osk* mRNA in association with eIF4E and Bru by inhibiting recruitment of the small ribosomal subunit to the 5′ cap ([@bib11], [@bib47], [@bib68]). Moreover, Cup/Maskin/4E-T binds eIF4E and prevents it from associating with the translation initiation machinery ([@bib7], [@bib34], [@bib45], [@bib58], [@bib63]). Cup also works through repression of oo18 RNA binding protein (Orb), the *Drosophila* homolog of cytoplasmic polyadenylation element binding protein (CPEB) ([@bib39], [@bib69]). Orb is required for the translational activation of *osk* mRNA by elongating its poly(A) tail ([@bib9], [@bib8], [@bib32]), and high levels of Orb protein expression in the oocyte are ensured by the translational activation of *orb* mRNA by Orb protein ([@bib64]). This feedback loop is controlled by the negative action of Cup, Ypsilon Schachtel (YPS), and *Drosophila* fragile X mental retardation (dFMR1) on *orb* translation ([@bib14], [@bib42], [@bib69]).

*bcd* mRNA is thought to be silenced in a similar manner as *osk*, but it utilizes a different translational repressor, Pumilio (Pum), which binds to conserved Nanos response elements (NREs) in the *bcd* 3′ UTR ([@bib22]). Similarly, Glorund ([@bib33]) and Smaug ([@bib48], [@bib72]) bind to a translational control element (TCE) in the 3′ UTR of unlocalized *nos* mRNA to repress its translation ([@bib15]). During mid-oogenesis, our previous work has shown that localized *bcd* is translationally repressed in the core of processing bodies (P bodies), which consist of RNP complexes that are thought to regulate transcript stability and translation in a variety of systems ([@bib16], [@bib67]). In the *Drosophila* oocyte, P bodies lack ribosomes and contain translational repressors, including the DEAD-box helicase maternal expression at 31B (Me31B) and Bru ([@bib17], [@bib67]).

In contrast, there is less consensus regarding the mechanism*s* that are required for translational control of *grk* mRNA, particularly repression in nurse cells. Early in oogenesis, *grk* mRNA is localized and translated at the posterior of the oocyte, followed by a second phase of localization and localized expression at the dorso-anterior (DA) corner from mid-oogenesis. *grk* encodes a transforming growth factor α (TGF-α)-like signal that is secreted to the surrounding follicle cells to pattern dorsal cell fates ([@bib49]). Dorso-ventral patterning also requires the heterogeneous nuclear RNP (hnRNP) Squid (Sqd), which has been shown to be necessary for correct Grk protein expression in the oocyte ([@bib6], [@bib13], [@bib36], [@bib40], [@bib51]). Although *grk* mRNA has been shown by biochemical analysis on ovaries ([@bib51]) to complex with Bruno through BRE-like sequences in its 3′ UTR, these match only weakly the BREs found in *osk* ([@bib56]). Furthermore, fluorescent expression reporters containing the BRE-like sequences from the *grk* 3′ UTR are subject to a low level of Bruno-mediated translational repression when compared with those containing *osk* BREs ([@bib56]).

We have previously established that, in the oocyte, *grk* mRNA is translationally repressed in transport particles and is then translated at its final destination in the DA corner of the oocyte, where it associates, in contrast to *bcd*, with the edge of P bodies ([@bib67]). Importantly, the edge of P bodies has been shown to be decorated with ribosomes and enriched with Orb and Sqd ([@bib13], [@bib17], [@bib39], [@bib40], [@bib51], [@bib67]). Interestingly, Orb has been shown to be required for the translation of *grk*, *osk*, and other localized mRNAs in the oocyte ([@bib8], [@bib9], [@bib10], [@bib32], [@bib64]), and recently, Orb, together with Wispy (Wisp), a poly(A) polymerase, has been shown to be required for *grk* polyadenylation and Grk protein expression ([@bib52]). Indeed, phosphorylated, active Orb recruits Wispy and is required for the hyperadenylation and translation of *grk* ([@bib52], [@bib70]). However, it remains unclear when and where Orb acts in *grk* mRNA-localized expression in vivo and whether Orb association with P bodies is required to regulate *grk* translation.

Here, we address the mechanism in vivo by which translation of *grk* mRNA is prevented during its transport through nurse cells. We first tested the individual roles of previously suggested translational repressor proteins in the *Drosophila* egg chamber, including Me31B, Bru, and Sqd. We found that *grk* mRNA translational repression in nurse cells is not crucially dependent on any of these known repressors when tested individually, nor is *grk* present in the translationally silent core of P bodies in nurse cells. Instead, using immunofluorescence and electron microscopy, we found that wild-type nurse cell P bodies contain markedly lower levels of Orb compared with those in the oocyte. Increasing the levels of Orb protein within nurse cells by two independent methods causes *grk* mRNA to associate abnormally with nurse cell P bodies and also causes ectopic *grk* translation in nurse cells. Therefore, our data lead us to propose a model for spatial regulation of *grk* mRNA translation during *Drosophila* oogenesis in which *grk* transcripts are prevented from being translated in nurse cells by being denied access to sufficiently high levels of Orb, whereas, in the oocyte, *grk* is translated when it is anchored with Orb at the edge of P bodies.

Results {#sec2}
=======

*grk* Translational Silencing in Nurse Cells Is Not Dependent on Individual Translational Repressors as in *osk* Repression {#sec2.1}
---------------------------------------------------------------------------------------------------------------------------

Me31B and Bru are known to be crucial translational repressors of *osk* mRNA during its transport to the posterior of the oocyte because removal of each individually is sufficient to cause premature Osk protein expression ([@bib11], [@bib46], [@bib47], [@bib68]). We tested whether these regulators also individually repress *grk* mRNA translation during its transport. We first visualized the distribution of Grk protein in fly strains mutant for *me31B* using *me31B* heat shock-inducible germline clones ([@bib46]). We found that, in *me31B*-null egg chambers, Grk protein is only expressed in the oocyte ([Figure 1](#fig1){ref-type="fig"}A), as in the wild-type. Similarly, Grk expression is unaffected in a number of allelic mutant combinations of *aret* (Bru mutant) ([@bib71]; [Figures 1](#fig1){ref-type="fig"}B and 1B′; [Figure S1](#mmc1){ref-type="supplementary-material"}). We also tested the role of Sqd, a heterogeneous nuclear RNA-binding protein, known to be required for *grk* mRNA anchoring ([@bib17]) and translational repression in the oocyte ([@bib6], [@bib13], [@bib40], [@bib51]). In *sqd*^1^ mutant oocytes, Grk protein is ectopically expressed along the entire anterior margin, resulting is a dorsalized egg ([Figure 1](#fig1){ref-type="fig"}C versus [Figure 1](#fig1){ref-type="fig"}C′) ([@bib36], [@bib51]). However, we found that Grk protein is not expressed in nurse cells of *sqd*^1^ mutant egg chambers, showing that Sqd is not required for repressing *grk* translation in nurse cells ([Figure 1](#fig1){ref-type="fig"}C′). Collectively, we conclude that, unlike *osk*, none of the factors we tested individually repress *grk* mRNA translation during its transport in nurse cells.Figure 1*grk* Does Not Require Translational Repressors to Maintain Translational Silencing in Nurse Cells(A--A′′) Homozygous Me31B-null germline clones generated by the flippase/flippase recognition target (FLP/FRT) system. (A) Loss of Me31B is marked by loss of Vasa-GFP fusion protein. Inset: schematic illustrating the relative position of the oocyte and nurse cells for a stage 5/6 egg chamber. (A′ and A′′) Grk protein expression is restricted to the oocyte, with no staining in the nurse cells (n = 30). The asterisk marks a Vasa-GFP-positive egg chamber that is not an Me31B mutant. Egg chambers fail to develop to mid oogenesis in the *me31B* mutant background.(B--D) In wild-type (WT) egg chambers, Grk protein expression is restricted to the oocyte, around the oocyte nucleus at mid-oogenesis (n = 30).(B) Inset: schematic illustrating the relative position of the oocyte and nurse cells for a stage 8 egg chamber.(B′) In weak *aret* mutants, the same pattern is observed (n = 60), with no ectopic staining in nurse cells. The same result is seen in medium and strong *aret* allelic combinations ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B).(C′) In *sqd*^1^ egg chambers, Grk protein is expressed along the anterior margin but not in nurse cells (n = 60).(D′) In egg chambers overexpressing *grk* using the UAS-Gal4 system, Grk expression is restricted to the oocyte and is not expressed in nurse cells (n = 30) ([Figure S2](#mmc1){ref-type="supplementary-material"}).Scale bars, 15 μm. NC, nurse cell; Ooc, oocyte; n, oocyte nucleus. Dashed lines indicate the edges of the egg chamber.

Ectopically expressing *osk* mRNA leads to ectopic Osk protein expression in nurse cells, suggesting that the *osk* repression machinery is saturated by an excess of *osk* mRNA ([@bib62]). To test whether a similar saturable mechanism exists to repress *grk* mRNA translation, we ectopically expressed *grk* mRNA to saturate any putative repression machinery. We used the UAS-Gal4 system to overexpress full-length *grk* transcripts ([@bib4], [@bib67]) at an average of 3-fold the level in wild-type nurse cells ([Figure S2](#mmc1){ref-type="supplementary-material"}). This results in ectopic Grk expression, but only along the anterior margin of the oocyte, not in nurse cells ([Figure 1](#fig1){ref-type="fig"}D versus [Figure 1](#fig1){ref-type="fig"}D′). These data strengthen the notion that, in contrast to *osk*, *grk* translation in nurse cells is not mediated through the saturable binding of repressors.

*grk* mRNA Associates Differently with P Bodies in Nurse Cells and Oocytes {#sec2.2}
--------------------------------------------------------------------------

We next tested whether *grk* is maintained in a translationally silent state in nurse cells by localization to the ribosome-depleted and translationally silent core of P bodies in a similar manner to *bcd* in the oocyte ([@bib67]). We visualized *grk* mRNA in nurse cells with single-molecule fluorescence in situ hybridization (smFISH) ([@bib41]) of egg chambers expressing *Me31B::GFP*, a canonical marker for P bodies in the oocyte ([@bib67]). We found that small foci of *grk* mRNA, similar but weaker in intensity than oocyte transport particles ([Figure S2](#mmc1){ref-type="supplementary-material"}A and S2A′), are evenly distributed in the nurse cell cytoplasm, with only a minority associated with the edge of nurse cell P bodies ([Figures 2](#fig2){ref-type="fig"}A and 2A′′).Figure 2*grk* mRNA Is Not Associated with P Bodies in Nurse Cells(A--A′′) In egg chambers expressing Me31B::GFP, P bodies rarely associate (16% of particles, n = 297) with *grk* mRNA particles labeled with single-molecule FISH in the nurse cell cytoplasm. (A) Me31B::GFP labeling P bodies, (A′) *grk* mRNA particles labeled with single-molecule FISH, and (A′′′) overlay of Me31B::GFP labeling P bodies in green and single-molecule FISH labeling *grk* mRNA in red.(B--B′′′) Consecutive time points in a time-lapse series of a live egg chamber expressing *grk*^∗^*mCherry* and Me31B::GFP. *grk* particles (arrowheads) move independently of Me31B assemblies in the nurse cell cytoplasm (n = 89). Dashed red circles indicate the positions of *grk* particles at t = 0 s.(C--E) In early oogenesis, *grk* localized to the oocyte posterior where it is locally translated.(C) *grk* smFISH on an early-stage egg chamber showing the localization of *grk* at the posterior (arrowheads) (n = 5). Inset: schematic illustrating the relative position of the oocyte and nurse cells for a stage 5/6 egg chamber.(D) Anti-Grk antibody labeling showing the gradient in Grk protein from a local enrichment at the posterior (arrowheads) (n = 5).(E) Anti-Orb antibody labeling showing increased Orb in the oocyte (arrowheads) (n = 5).(F--F′′′) Early-stage living egg chamber expressing *grk^∗^mCherry* and Me31B::GFP showing local docking of *grk* on Me31B-labeled P bodies at the posterior, taken from a time-lapse series (n = 4). (F) Composite image showing the interdigitation of *grk* with Me31B at the posterior. (F′) Enlargement of the region identified by the dashed box in (F). (F′′) Me31B::GFP showing the decreasing gradient in P body density from posterior to anterior. (F′′′) *grk^∗^mCherry* showing the locally docked *grk* mRNA at the posterior.Scale bars, 2 μm (A and B) and 10 μm (C and F).

To test whether *grk* associates with P bodies in nurse cells at mid-oogenesis, we co-visualized *grk* in live nurse cells with the MS2-MCP system (*grk*^∗^*mCherry*) ([@bib1], [@bib20], [@bib31]) and a number of proteins labeled by fluorescent protein traps ([@bib5]). We found that *grk*^∗^*mCherry* particles do not move with Me31B in nurse cells and transiently associate with P bodies at a significantly lower frequency (8%; n = 486) than in the oocyte (41%) ([@bib67]; [Figures 2](#fig2){ref-type="fig"}B--2B′′′). These data suggest that, within our detection limits, *grk* mRNA does not move with P body proteins and is not localized to the interior of P bodies. We also tested whether the same was true at early stages by assessing the distribution of *grk* mRNA, Grk protein in fixed material ([Figures 2](#fig2){ref-type="fig"}C and 2D), and the interaction of *grk* mRNA with P bodies in live material ([Figures 2](#fig2){ref-type="fig"}F--2F′′′). We found that, in early stages, before the oocyte nucleus migrates, *grk* mRNA particles are dynamic all over the egg chamber, except when they are associated with P bodies at the posterior of the oocyte ([Figure 2](#fig2){ref-type="fig"}F′), where Orb is enriched ([Figure 2](#fig2){ref-type="fig"}E). We also found that Grk protein was enriched at the posterior of the oocyte and present at lower levels in other parts of the oocyte in a gradient that is consistent with diffusion away from its site of translation at the posterior ([Figure 2](#fig2){ref-type="fig"}D). Considering all of our data, we conclude that *grk* mRNA is likely to be translated at its site of anchoring in both early and late stages of *grk* mRNA localization. Moreover, *grk* mRNA is unlikely to be repressed by association with known saturable translational repressors either in the nurse cell cytoplasm or within P bodies.

The Translational Activator Orb Is Largely Depleted in Nurse Cells {#sec2.3}
------------------------------------------------------------------

Although we cannot completely eliminate the possibility that *grk* translation is controlled by a redundant and/or yet to be identified repression mechanism, our data prompted us to examine known translation activators such as Orb. To address this, we first re-characterized *orb*^mel^ mutants that expresses a truncated version of *orb* mRNA, resulting in lower levels of Orb protein from stage 7 of oogenesis onward ([@bib12]). We observed a loss of Grk expression in *orb*^mel^ mutants ([Figure S3](#mmc1){ref-type="supplementary-material"}), in agreement with previously published data ([@bib10]). To begin to understand why *grk* mRNA is translated in wild-type oocytes but not in the nurse cells, we characterized the distribution of Orb protein in P bodies in the two compartments using immuno-electron microscopy (IEM) on ultrathin frozen sections of *Drosophila* egg chambers ([Figure 3](#fig3){ref-type="fig"}; [Figure S4](#mmc1){ref-type="supplementary-material"}). We found that the level of Orb protein in nurse cell P bodies is 18 times lower than in oocyte P bodies (n = 10 P bodies; [Figure 3](#fig3){ref-type="fig"}D versus [Figure 3](#fig3){ref-type="fig"}D′). Using immuno-fluorescence detection on fixed egg chambers, we confirmed that the overall level of Orb is much lower in nurse cells compared with oocytes ([Figures 3](#fig3){ref-type="fig"}E, [4](#fig4){ref-type="fig"}A, and 4C).Figure 3P Bodies in Nurse Cells Contain Similar Proteins as those in the Oocyte but Have Significantly Lower Levels of Orb(A--D′) Protein detection by IEM on ultrathin frozen sections of nurse cells. Dashed black lines mark the edge of P bodies.(A--A′′) Anti-Me31B (10 nm) is highly enriched in the core of P bodies in the oocyte (A) and nurse cells (A′). A′′ is a lower-magnification image showing P bodies containing Me31B in both nurse cells and the oocyte. The solid black line marks the boundary between the nurse cells and the oocyte.(B) Anti-Bru (15 nm) is highly enriched in the P body core and in P bodies at the dorso-anterior corner of the oocyte. Proteins found at the core of P bodies in the oocyte are also detected in nurse cell P bodies by immunofluorescence ([Figure S5](#mmc1){ref-type="supplementary-material"}). The cyan line marks the boundary between the nurse cells and the oocyte.(C) Anti-ribo 490 (10 nm) shows ribosomes predominantly excluded from P bodies in nurse cells.(D and D′) Anti-Orb (15 nm) is present in P bodies in the oocyte and is enriched at the edge (D, see also [Figure S4](#mmc1){ref-type="supplementary-material"}), but P bodies in nurse cells contain significantly lower levels of Orb (D′).(E--E′′) Nurse cell-oocyte boundary of the DA corner of an egg chamber expressing Me31B::GFP (E) stained with anti-Orb (E′) (n = 30). P bodies in the nurse cell cytoplasm express significantly lower levels of Orb compared with in the oocyte. (E) Me31B::GFP labeling P bodies, (E′) Anti-Orb labeling Orb protein, and (E′′′) overlay of Me31B::GFP labeling P bodies in green and anti-Orb labeling Orb protein in red.Scale bars, 200 nm (A--A′′, B, C, D, and D′) and 10 μm (E).Figure 4When Orb Is Upregulated, *grk* Is Ectopically Translated in Nurse Cells(A and A′) Antibody staining using anti-Orb. In WT egg chambers, Orb is expressed at significantly higher levels in the oocyte than in the nurse cells (A) (n = 258). In egg chambers overexpressing orb using the UAS-Gal4 system, Orb is overexpressed in both the nurse cells and the oocyte in puncta (A′) (n = 60).(B and B′) Antibody staining using anti-Grk. In WT egg chambers, Grk expression is restricted to the oocyte and is localized to the dorso-anterior corner (B) (n = 300). In egg chambers overexpressing orb using the UAS-Gal4 system, Grk is expressed both throughout the oocyte and also in nurse cells along cell-cell boundaries (B′) (n = 60).(C and C′) Antibody staining using anti-Orb of a stage 6 egg chamber. In WT egg chambers, Orb is expressed at significantly higher levels than in nurse cells (C). In *cup*^1355^ mutant egg chambers, Orb is overexpressed in nurse cells compared with the oocyte (C′) (n = 238).(D and D′) Antibody staining using anti-Grk. In WT egg chambers Grk expression is restricted to the oocyte and is localized to the dorso-anterior corner (D) (n = 300). In cup^1355^ mutant egg chambers, Grk is expressed in nurse cells along cell-cell boundaries (D′) (n = 274). The staining in nurse cells is noticeably stronger than in egg chambers overexpressing Orb using the UAS-Gal4 system.Scale bars, 15 μm. Dashed yellow lines indicate the edges of the egg chamber, and dashed cyan lines delineate the oocyte boundary.

We then tested whether the overall composition of the nurse cell P bodies was different from those in the oocytes. We found that the key P body markers Me31B ([Figure 3](#fig3){ref-type="fig"}A) and Bru ([Figure 3](#fig3){ref-type="fig"}B) have a similar enrichment in nurse cells and the oocyte and that ribosomes are excluded from the nurse cell P bodies as they are from P bodies in the oocyte ([Figure 3](#fig3){ref-type="fig"}C). We also visualized P body protein composition by immunofluorescence and found that Me31B co-localizes with the canonical P body components Trailerhitch (Tral), Growl, eIF4E, Cup, and YPS in P bodies in nurse cells as they do in the oocyte ([Figure S5](#mmc1){ref-type="supplementary-material"}). We conclude that the difference in Orb protein content of the P bodies in the two tissues is specific and that Orb is relatively depleted from nurse cell P bodies compared with those in the oocyte.

Orb Is a Key Determinant for *grk* Translation in Nurse Cells {#sec2.4}
-------------------------------------------------------------

To test whether low abundance of Orb in nurse cells is the key factor that prevents *grk* mRNA translation, we used the UAS-Gal4 system to drive the level of Orb in nurse cells to a similar level as in the wild-type oocyte (*UASp-orb* and *TubulinGal4VP16*) ([@bib40]). This approach also results in a higher level of Orb protein in the oocyte of these egg chambers ([Figure 4](#fig4){ref-type="fig"}A versus [Figure 4](#fig4){ref-type="fig"}A′). Importantly, in these egg chambers, Grk protein is ectopically expressed in nurse cells in a highly reproducible pattern along nurse cell boundaries ([Figure 4](#fig4){ref-type="fig"}B versus [Figure 4](#fig4){ref-type="fig"}B′), as expected for a secreted protein that is normally trafficked into the overlying follicle cells when expressed at the DA corner ([@bib54]). We conclude that the ectopic expression of Orb in nurse cells drives the premature translation of *grk* mRNA in nurse cells. We propose that the absence of *grk* translation in wild-type nurse cells is due to the low level of Orb in this tissue.

Previous work has shown that *orb* transcripts can be detected in nurse cells as well as in the oocyte ([@bib69]) but that *orb* translation is repressed by Cup in nurse cells ([@bib69]). To test whether Cup is required to suppress the translation of *orb* mRNA in nurse cells and thus prevent *grk* translation, we stained *cup* mutant egg chambers with antibodies against Grk. We used *cup*^1355^, in which a P element insertion into the untranslated exon 1 causes a reduction in the level of Cup protein expression ([@bib35]). As expected, we found an upregulation of Orb in *cup*^1355^ mutant nurse cells ([Figure 4](#fig4){ref-type="fig"}C versus [Figure 4](#fig4){ref-type="fig"}C′; n = 238), and, strikingly, we found that Grk protein is expressed in nurse cells and enriched along cell-cell boundaries, as in *UAS-orb* egg chambers ([Figure 4](#fig4){ref-type="fig"}D versus [Figure 4](#fig4){ref-type="fig"}D′). Interestingly, we found that Grk protein expression is stronger in *cup*^1355^ than *UAS-orb* egg chambers. This is consistent with Cup partly repressing excess Orb in *UAS-orb* egg chambers, whereas, in *cup*^1355^, *orb* translation is fully derepressed because of the lack of Cup. These results show that, when Cup-mediated repression of *orb* mRNA is absent in egg chambers, Orb is upregulated in nurse cells and *grk* is translated.

*grk* Is Translationally Activated by Ectopic Orb on the Edge of Nurse Cell P Bodies {#sec2.5}
------------------------------------------------------------------------------------

At the DA corner of the oocyte, and most likely also at the posterior earlier in oogenesis, *grk* is translated when it docks at the Orb-enriched edge of P bodies ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}A, and 4C; [@bib67]). If the key functional difference between P bodies in the oocyte and nurse cells is their level of associated Orb, then one would expect to find Orb at the edge of the nurse cell P bodies when it is ectopically expressed there. To test this prediction, we first examined Orb and Me31B distribution in the nurse cells of *UAS-orb* egg chambers and found that they colocalize ([Figure 5](#fig5){ref-type="fig"}A). Similarly, we found that Orb co-localizes with Tral in the nurse cells of *cup*^1355^ mutant egg chambers ([Figure 5](#fig5){ref-type="fig"}B). To test whether ectopic Orb is enriched at the edge of nurse cell P bodies as it is in the oocyte, we performed 3D structured illumination microscopy (3D-SIM) ([@bib60]) on the OMX microscope ([@bib18]). 3D-SIM reveals Orb puncta present at the edge of the Me31B-labeled P bodies in nurse cells ([Figures 5](#fig5){ref-type="fig"}C--5C′′). We conclude that ectopic Orb in nurse cells is enriched at the edge of P bodies as it is at the DA corner of the oocyte.Figure 5When Orb Is Upregulated, It Is Expressed at the Edge of Nurse Cell P Bodies, and *grk* Is Targeted to P Bodies in Nurse Cells(A) Nurse cell cytoplasm of an egg chamber expressing *Me31B::GFP* and overexpressing *orb* using the UAS-Gal4 system, stained with anti-Orb. Orb and Me31B co-localize in P bodies in the nurse cell cytoplasm. The image is a 4-μm average intensity projection (n = 30).(B) Nurse cell cytoplasm of a *cup*^1355^ mutant egg chamber that is also expressing *Tral::YFP*, stained with anti-Orb. Orb and Tral co-localize in P bodies in the nurse cell cytoplasm (n = 30). The image is a 4-μm average intensity projection.(C--C′′) 3D-SIM of the nurse cell cytoplasm of an egg chamber expressing *Me31B::GFP* and overexpressing *orb* using the UAS-Gal4 system, stained with anti-Orb. 3D-SIM resolves Orb puncta, which are enriched at the edge of the Me31B-labeled P body that has a reticulated structure, as shown previously ([@bib67]). (C) Me31B::GFP labeling P bodies, (C′) anti-Orb labeling Orb protein, and (C′′) overlay of Me31B::GFP labeling P bodies in green and anti-Orb labeling Orb protein in red.(D) In OrR egg chambers, *grk* particles in nurse cells (D′) rarely colocalize with P bodies (D′′) in nurse cells (16% of particles, n = 297).(E) In *UAS-orb* egg chambers, *grk* particles in nurse cells (E′) colocalize with P bodies (E) (53% of particles, n = 395) and seem to be docked at the P body edge (E′′).Scale bars, 2 μm (A, B, and D--E′′) and 1 μm (C--C′′).

To test whether ectopically expressing Orb in nurse cells targets *grk* to the edge of P bodies, allowing its translation, we performed smFISH for *grk*. As mentioned above, we found that, in nurse cells of wild-type egg chambers, *grk* seldom colocalizes with P bodies ([Figures 2](#fig2){ref-type="fig"}A and [5](#fig5){ref-type="fig"}D--5D′′). Conversely, in egg chambers in which Orb is ectopically expressed in nurse cells, *grk* foci colocalize 3-fold more with P bodies compared with the wild-type ([Figures 5](#fig5){ref-type="fig"}E--5E′′). We conclude that overexpressed ectopic Orb associates with P bodies anchoring *grk* transcripts to activate translation. Therefore, we propose that *grk* is not translated in the nurse cells of wild-type egg chambers because, unlike in the oocyte, Orb is not present in nurse cells at the edge of P bodies.

Discussion {#sec3}
==========

Our results show that the translational regulation of *grk* in nurse cells, where the transcript is synthesized, occurs by a different mechanism from that of *osk* and *bcd* mRNA in the oocyte. *osk* is primarily translationally regulated by binding to individually essential translational repressors ([@bib46], [@bib47], [@bib11]), whereas *bcd* is translationally repressed through its inclusion in the ribosome-depleted interior of P bodies ([@bib67]). In contrast, our results show that translational silencing of *grk* mRNA during its transport in nurse cells is not affected when the repressors affecting *osk* are individually removed and that it is not localized within P bodies while being transported and repressed. These observations highlight a major difference in the mechanisms of translational repression between *grk, bcd*, and *osk*.

Although the translational activation of *grk* mRNA at its final destination in the oocyte has been shown to require the polyadenylation factor and activator Orb ([@bib10], [@bib52]), probably at the edge of P bodies ([@bib67]), its role during the transport of *grk* in nurse cells has not been previously addressed. Our data show that the relative depletion of Orb from nurse cells compared with the oocyte is sufficient to prevent *grk* mRNA from being translated in nurse cells. We further show that P bodies are present in wild-type nurse cells and that they have the same apparent composition and ultrastructure as in the oocyte, except that they lack Orb and *grk* mRNA. Interestingly, when Orb expression is driven in nurse cells to similar levels as occur in the wild-type oocyte using UAS-Orb, we find that Orb and *grk* mRNA are associated with nurse cell P bodies, leading to *grk* mRNA premature translation in nurse cells. These results suggest that the absence of Orb in nurse cells is the limiting factor that prevents *grk* translation before it arrives in the oocyte.

We also obtained similar results using a *cup* mutant in which Orb levels are higher in nurse cells. Why cup normally represses Orb expression only in nurse cells is unclear, but we nevertheless found that *grk* is prematurely translated in nurse cells of *cup* mutants. Based on our results above and previously published work ([@bib69]), we favor the simplest interpretation: that, in *cup* mutants, Orb expression is elevated sufficiently to allow *grk* translation. However, we cannot completely exclude the possibility that Cup could also be involved directly in repressing *grk* translation in nurse cells through Cup's known role in excluding eIF4E in the case of other transcripts ([@bib47], [@bib68]). Whether Cup acts by influencing Orb alone or also acts directly on *grk* mRNA translation, Cup and Orb spatially regulate translation of *grk* mRNA in egg chambers. It is interesting to note that, in *Xenopus,* CPEB activation of the translation of mRNA in the oocyte is temporally rather than spatially regulated through the action of hormone signals ([@bib59]), leading to activation of translation at precisely orchestrated times by lengthening of poly(A) tails ([@bib24]).

Consistent with the published literature and its canonical function, Orb most likely acts on *grk* through cytoplasmic polyadenylation by binding to a polyadenylation element at the 3′ end of *grk* mRNA near the polyadenylation hexanucleotide signal (AAUAAA) ([@bib9], [@bib21], [@bib37], [@bib52], [@bib64]). Such an activity for Orb protein was first established for its homolog in *Xenopus*, CPEB ([@bib21], [@bib24]). Orb is also known to bind *osk* and *k(10)* mRNAs and control their translation by modulation of poly(A) tail length ([@bib8], [@bib9], [@bib10], [@bib32], [@bib64], [@bib69]). Although there is no direct evidence that Orb binds *grk* mRNA, recent work shows that Orb and Wispy cooperate to polyadenylate localized *grk* mRNA in egg chambers ([@bib10], [@bib52]). It is certainly possible to imagine alternative models for how Orb acts on *grk*, such as polyadenylating and promoting the translation of other translational activators of *grk*. However, in the absence of any further direct evidence for such alternative mechanisms, we favor the simpler interpretation that Orb acts directly on *grk* by polyadenylating it and activating its translation.

Considering all of our data in the context of previously published work, we propose the following model for translational regulation of *grk* mRNA. While being transported in the nurse cell cytoplasm, *grk* mRNA is not translated because it fails to associate with Orb at the edge of P bodies. Only when *grk* enters the oocyte and moves to the dorso-anterior corner, where Orb levels are highest, does it become associated with Orb on the edge of P bodies, causing its localized translational activation ([Figure 6](#fig6){ref-type="fig"}).Figure 6*grk* Is Translationally Silenced in Nurse Cells by Being Denied Access to Its Translational Activator, OrbA model of *grk* translational regulation by restricted spatial access to Orb. In the nurse cells of *WT* egg chambers, P bodies lack in Orb. *grk* mRNA does not dock with P bodies and is not translated. At the oocyte DA corner, Orb is enriched at the edge of P bodies where *grk* mRNA docks. *grk* is translated and then secreted to the follicle cells around the oocyte nucleus.

Previous work indicates that *grk* translation is restricted to the posterior in early oocytes and at the DA corner at mid-oogenesis ([@bib10], [@bib49], [@bib50]). More recent work suggests that this restricted translation is due to localization of active, phosphorylated Orb ([@bib52], [@bib69]). This may provide a plausible explanation for why *grk* mRNA does not associate with P bodies containing Orb in the middle of the oocyte; namely, if Orb is only phosphorylated and active in the DA corner. However, we cannot exclude the possibility that other factors, such as PABP55B, Encore (Enc), and Sqd, could also be required in the oocyte for localized *grk* translation ([@bib13], [@bib25], [@bib26], [@bib65]). Certainly, Sqd protein has been shown to bind *grk* mRNA directly and to regulate its translation ([@bib40], [@bib43], [@bib51]), possibly through anchoring, because previous work has also shown that, in the absence of Sqd protein, *grk* mRNA fails to anchor at the oocyte DA corner and is ectopically translated along the anterior ([@bib6], [@bib17], [@bib31], [@bib51]). Our data show that Sqd does not repress *grk* mRNA translation in nurse cells, leading us to interpret the function of Sqd in repression of *grk*, identified by previous biochemical work ([@bib40]), as occurring in the oocyte and not in nurse cells.

The well studied localized mRNAs *osk*, *bcd*, *grk*, and *nos* each have distinct profiles of translational regulation in time and space. For example, *osk* and *grk* are transported in a repressed state and are translationally activated when they arrive at their final destinations in the oocyte ([@bib19], [@bib49]), whereas localized *bcd* remains repressed within P bodies until egg activation ([@bib67]). Our results suggest that spatial regulation of translation can be achieved by restricting the levels of a single activator, Orb. We propose that this could be a widespread mechanism of preventing translation of localized transcripts while they are being transported to their final destination.

Experimental Procedures {#sec4}
=======================

Fly Strains {#sec4.1}
-----------

Stocks were raised on standard cornmeal-agar medium at 25°C. The wild-type was Oregon R (OrR). Mutant lines were as follows: *hsFLP/w ; me31B*^Δ1^ *FRT40A, hsFLP/w ; me31B*^Δ2^ *FRT40A* ([@bib46]); *aret*^PD^, *aret*^PA^, and *aret*^QB^ ([@bib61]); *squid*^1^ ([@bib36]); and *cup*^1355^ ([@bib35]). The heat shock marker line was *hsFLP/w ; gfp-vas FRT40A*. *MS2-MCP(FP)* lines were as follows: *grk - (MS2)*^12^ ([@bib31]) and *Pnos-NLS-MCP-mCherry* ([@bib67]). P body markers were as follows: *Me31B::GFP* ([@bib5]) (CG4916), *Tral::YFP* (D. St Johnston CG10686), *Growl::GFP* ([@bib5]) (CG14648), *eIF-4E::GFP* ([@bib5]) (CG4035), *Cup::YFP* (D. St Johnston, CG11181) *YPS::GFP* ([@bib5]) (ZCL1503). Overexpression lines were as follows: maternal tubulin driver TubulinGal4-VP16; *UASp grk3A* based on genomic sequence DS02110, which includes the full 3′ and 5′ UTRs ([@bib4]), and *UASp-orb* ([@bib40]). The deficiency line was *Df(2L)esc-P2-0* (Bloomington, BL3130). For Me31B germline clones, the heat shock regime was performed as described previously ([@bib46]).

Electron Microscopy Sample Preparation and Analysis {#sec4.2}
---------------------------------------------------

Protein detection was performed by IEM as described previously ([@bib17], [@bib27], [@bib67]).

Antibodies {#sec4.3}
----------

The antibodies used were Grk, mouse monoclonal (Developmental Studies Hybridoma Bank \[DSHB\], 1D-12, 1:300), Orb 4H8 (DSHB, 1:30), Me31B (a gift from A. Nakamura, 1:1000), Bruno (a gift from A. Ephrussi, 1:300), and α ribo-490 (a gift from J. Van Minnen, 1:300).

Fluorescence Imaging {#sec4.4}
--------------------

Flies were prepared and ovaries dissected and mounted for imaging according to standard protocols ([@bib17], [@bib53], [@bib67]). Unless otherwise stated, the egg chambers shown in the figures were mid-oogenesis (stages 7--9). Imaging was performed on a DeltaVision CORE wide-field deconvolution system (Applied Precision, a subsidiary of GE Healthcare) based on an Olympus IX71 microscope using ×20 0.75 numerical aperture (NA) dry, ×100 1.4 NA oil, and ×100 1.3 NA silicon oil objectives, a 16-bit Roper Cascade II camera, and standard Chroma filter sets. Where required, images were deconvolved with the SoftWoRx Resolve 3D constrained iterative deconvolution algorithm (Applied Precision). For live-cell imaging, *grk* mRNA particles were imaged close to the nurse cell nuclei at a single shallow plane of focus. Exposures of 300 ms at 3 frames/second were taken **t**o achieve the optimum balance between signal-to-noise and temporal resolution for deconvolution and particle tracking. Analysis of fluorescence intensity in Orb antibody-stained egg chambers was performed using FIJI (V1.0, <http://fiji.sc/wiki/index.php/Fiji>). 3D-SIM imaging was performed on the OMX V3 microscope (GE Healthcare) as described previously ([@bib67]).

Immunofluorescence on Fixed *Drosophila* Oocytes {#sec4.5}
------------------------------------------------

Adult females flies were fattened as described above. An optimized fixation and staining protocol was then used to reduce possible antibody penetration artifacts that can be associated with immunofluorescence. Flies were dissected directly into freshly made 4% paraformaldehyde in PBST (0.1%) (paraformaldehyde stock solution: 16% methanol-free, ultrapure EM grade, Polysciences). Ovarioles were splayed using tweezers and a probe (Fine Science Tools) but not fully separated. Individual ovaries were transferred into an Eppendorf tube, and then 800 μl heptane was added before mixing briefly by vortex. Ovaries were fixed for no more than 15 min in total, followed by three rinses and three washes of 10 min in PBST. Following PBST washes, ovaries were washed for 5 min in PBS with Triton X-100 (PBTX, 0.01%) and then rinsed in PBST. Ovaries were blocked in 4% BSA in PBST for 30 min. Primary antibody was added at the required concentration in PBST for 2 hr at room temperature, followed by three rinses and three washes of 20 min in PBST. Secondary antibody was added at 1:500 in PBST for 1 h at room temperature, followed by three rinses and three washes of 20 min in PBST. Ovaries were mounted on a glass slide in Prolong Gold antifade reagent (Life Technologies), and ovarioles were separated fully during mounting.

Single-Molecule FISH {#sec4.6}
--------------------

Single-molecule FISH was performed using Stellaris (Biosearch Technologies) oligonucleotide probes 20 nt in length complementary to the *grk* transcript (CG17610, 48 probes), conjugated to CAL Fluor Red 590. Fixed ovaries were washed for 10 min in 50% PBST, 50% Hybe− solution (10% deionized formamide, 2× SSC, 2 mM ribonucleoside vanadyl complex, and 0.02 BSA) and then 10 min in Hybe− solution before pre-hybridizing for 1 hr in Hybe+ solution (10% deionized formamide, 2× SSC, 2 mM ribonucleoside vanadyl complex, 0.02% BSA, and 10% dextran sulfate). Hybridization of probes was performed for 16--24 hr at a concentration of 25 nM in Hybe+ solution at 37°C. Ovaries were washed twice for 1 hr in wash buffer (15% deionized formamide and 2× SSC) and mounted in Prolong Gold for imaging.
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